XML 39 R32.htm IDEA: XBRL DOCUMENT
v3.21.4

SHARE CAPITAL - Disclosure of number of issued and outstanding stock options (Details) - Stock Options [Member] | 12 Months Ended |
--- | --- | ---
Sep. 30, 2021 shares $ / shares | Sep. 30, 2020 shares | Sep. 30, 2019 shares
Disclosure of classes of share capital [line items] |  |  |
Options Outstanding and Exercisable, Number of options | 1,025,807 | 150,000 | 0
Options Outstanding and Exercisable, Remaining life (Years) | 4 years 3 months 10 days | 4 years 9 months 21 days |
September 21, 2024 [Member] |  |  |
Disclosure of classes of share capital [line items] |  |  |
Options Outstanding and Exercisable, Number of options | 8,807 |  |
Options Outstanding and Exercisable, Exercisable | 0 |  |
Options Outstanding and Exercisable, Exercise price | $ / shares | $ 7.64 |  |
Options Outstanding and Exercisable, Remaining life (Years) | 2 years 11 months 23 days |  |
July 23, 2025 [Member] |  |  |
Disclosure of classes of share capital [line items] |  |  |
Options Outstanding and Exercisable, Number of options | 150,000 |  |
Options Outstanding and Exercisable, Exercisable | 150,000 |  |
Options Outstanding and Exercisable, Exercise price | $ / shares | $ 1.25 |  |
Options Outstanding and Exercisable, Remaining life (Years) | 3 years 9 months 21 days |  |
November 17, 2025 [Member] |  |  |
Disclosure of classes of share capital [line items] |  |  |
Options Outstanding and Exercisable, Number of options | 447,000 |  |
Options Outstanding and Exercisable, Exercisable | 30,500 |  |
Options Outstanding and Exercisable, Exercise price | $ / shares | $ 1.25 |  |
Options Outstanding and Exercisable, Remaining life (Years) | 4 years 1 month 17 days |  |
April 28, 2026 [Member] |  |  |
Disclosure of classes of share capital [line items] |  |  |
Options Outstanding and Exercisable, Number of options | 240,000 |  |
Options Outstanding and Exercisable, Exercisable | 0 |  |
Options Outstanding and Exercisable, Exercise price | $ / shares | $ 7.60 |  |
Options Outstanding and Exercisable, Remaining life (Years) | 4 years 6 months 29 days |  |
June 15, 2026 [Member] |  |  |
Disclosure of classes of share capital [line items] |  |  |
Options Outstanding and Exercisable, Number of options | 180,000 |  |
Options Outstanding and Exercisable, Exercisable | 0 |  |
Options Outstanding and Exercisable, Exercise price | $ / shares | $ 7.60 |  |
Options Outstanding and Exercisable, Remaining life (Years) | 4 years 8 months 15 days |  |

X
- Definition Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table. + References No definition available. + Details
Name: | ifrs-full_DisclosureOfClassesOfShareCapitalLineItems
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The exercise price of outstanding share options. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 2 -IssueDate 2020-01-01 -Paragraph 45 -Subparagraph d -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2020-en-r&anchor=para_45_d&doctype=Standard -URIDate 2020-01-01 + Details
Name: | ifrs-full_ExercisePriceOfOutstandingShareOptions2019
Namespace Prefix: | ifrs-full_
Data Type: | num:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition The number of share options outstanding in a share-based payment arrangement. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 2 -IssueDate 2020-01-01 -Paragraph 45 -Subparagraph d -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2020-en-r&anchor=para_45_d&doctype=Standard -URIDate 2020-01-01 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 2 -IssueDate 2020-01-01 -Paragraph 45 -Subparagraph b -Clause i -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2020-en-r&anchor=para_45_b_i&doctype=Standard -URIDate 2020-01-01 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 2 -IssueDate 2020-01-01 -Paragraph 45 -Subparagraph b -Clause vi -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2020-en-r&anchor=para_45_b_vi&doctype=Standard -URIDate 2020-01-01 + Details
Name: | ifrs-full_NumberOfOutstandingShareOptions
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:decimalItemType
Balance Type: | na
Period Type: | instant

X
- Definition The number of share options exercisable in a share-based payment arrangement. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 2 -IssueDate 2020-01-01 -Paragraph 45 -Subparagraph b -Clause vii -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2020-en-r&anchor=para_45_b_vii&doctype=Standard -URIDate 2020-01-01 + Details
Name: | ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:decimalItemType
Balance Type: | na
Period Type: | instant

X
- Definition The weighted average remaining contractual life of outstanding share options. [Refer: Weighted average [member]] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 2 -IssueDate 2020-01-01 -Paragraph 45 -Subparagraph d -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2020-en-r&anchor=para_45_d&doctype=Standard -URIDate 2020-01-01 + Details
Name: | ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | ifrs-full_ClassesOfShareCapitalAxis=drug_StockOptionsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | drug_ExpiryDateAxis=drug_ExpiryDateTwentyOneSeptemberTwoThousandAndTwentyFourMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | drug_ExpiryDateAxis=drug_ExpiryDateTwentyThreeJulyTwoThousandAndTwentyFiveMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | drug_ExpiryDateAxis=drug_ExpiryDateSeventeenNovemberTwoThousandAndTwentyFiveMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | drug_ExpiryDateAxis=drug_ExpiryDateTwentyEightAprilTwoThousandAndTwentySixMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | drug_ExpiryDateAxis=drug_ExpiryDateFifteenJuneTwoThousandAndTwentySixMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |